̹ | ǰ | |||
---|---|---|---|---|
ٴ ŸD 2000IU ÷ 400mg x 90ĸ | ǹ̿ | ǸŰ 15,710 |
||
ٴ ŸD 2000IU÷ 90ĸ 3 | ٴ | ǸŰ 47,120 |
||
ٴ ŸD 2000IU÷ 90ĸ 2 | ٴ | ǸŰ 31,420 |
||
ٴ ŸD 2000IU÷ 90ĸ | ٴ | ǸŰ 15,710 |
||
ٴ ŸD 2000IU ÷ 90ĸ 3 | ٴ | ǸŰ 51,080 |
||
ٴ ŸD 2000IU ÷ 90ĸ 2 | ٴ | ǸŰ 35,380 |
||
ٴ ŸD 2000IU ÷ 90ĸ | ٴ | ǸŰ 19,670 |
||
ŸC 1000 120x6 | () | ǸŰ 122,760 |
||
׳ ŸB6 (3) Ű ǰ | ()コɾ | ǸŰ 71,210 |
||
׳ ŸB6 (1) Ű ǰ | ()コɾ | ǸŰ 24,220 |
||
コɾ ׳ ŸB6 (1300mgx60ĸx3) ö̵ Ű ǰ | Phil Inter Pharma USA, Inc. | ǸŰ 71,210 |
||
(コɾ) ׳ + ŸB6 2 | PhilInterPharmaUSAInc. | ǸŰ 18,900 |
||
21 (RU-21) x 3Ʈ / ŸC ؼ | Ǹ̾ | ǸŰ 17,030 |
||
ƻ65500mg x 180 | ǸŰ 24,720 |
|||
ٴ ǰ Ÿ÷ Ÿc 20 5 | ٴ | ǸŰ 15,220 |
||
ٴ ǰ Ÿ÷ Ÿc 20 1 | ٴ | ǸŰ 3,080 |
||
ٴ ǰ Ÿ÷ Ÿc 20 10 | ٴ | ǸŰ 30,300 |
||
ٴ ǰ ŸD 1000 I U ǰ 6 | ٴ | ǸŰ 27,450 |
||
ٴ ǰ ŸD 1000 I U ǰ 3 | ٴ | ǸŰ 14,030 |
||
ٴ ǰ Ÿ÷ Ÿc 20 5 (ǰҰ) | ٴ | ǸŰ 15,220 |